Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Dawn of a European Health Data Space – Challenges

Posted on July 16th, 2020 by in Pharma R&D

The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality.

(more…)

The Dawn of a European Health Data Space – Opportunities

Posted on July 9th, 2020 by in Pharma R&D

At the beginning of 2020, the European Commission introduced a β€œEuropean strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing β€œthe benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and convenient public services.”

(more…)

Readying Your Workforce for Digital Transformation

Posted on June 23rd, 2020 by in Pharma R&D

Seeing it as key to innovation and competitive advantage, many businesses in the life sciences are learning to embrace digital transformation these daysβ€”in fact, with good reason, most view it as necessary for survival. But whether or not the process of adopting rapidly-evolving digital-age technologies will actually result in business success can really depend on how you do it.

(more…)

The FAIR Toolkit Helps Researchers with Data Challenges

Posted on June 16th, 2020 by in Pharma R&D

Since the spread of COVID-19 was first reported, researchers of all types have mobilized to meet the challenges its causative agent, SARS-CoV-2, presents to the world. Data scientists in particular have been quick to apply their expertise to the problems of identifying, tracking and predicting outbreaks; diagnosing COVID-19; identifying infected individuals and detecting non-compliance with virus countermeasures; discovering new therapeutic interventions or repurposing existing ones; and searching for a safe, effective vaccine.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. …
  6. 6